wisp semaglutide launches weight care vertical for women with hormonal imbalances Wegovy (Semaglutide) Weight Loss Injection

[DOI] [PubMed] [Google Scholar] 91.Lim S, Bae JH, Oh H, Hwang IC, Yoon YE, Cho GY

Clinical trials have demonstrated its efficacy, with participants reporting significant weight loss, far surpassing results seen with other medications

The test identifies variants in GLP1R, GIPR, FTO, and MC4R genes affecting appetite regulation, satiety signaling, and metabolic rate

"Every day patients share with us what a difference Ro has made in their lives, and seeing such improvements in their metabolic health is another example of the benefits that high-quality obesity care has." Beyond clinical outcomes, Ro recently published survey results on the quality of life improvements among patients enrolled in its Body membership

Clinical trial data and emerging real-world evidence demonstrate that most individuals regain a substantial portion of their lost weight after stopping semaglutide

This does not prove causality but suggests also the GIP might be beneficial or detrimental in cardiovascular diseases, but this warrants further work because even in animal studies controversy on the role of GIP in this regard exists